Antiprogestin-receptor complexes: differences in the interaction of the antiprogestin RU38,486 and the progestin R5020 with the progesterone receptor of human breast cancer cells.
In order to understand the molecular basis for antiprogestin action, we have compared the interaction of the antiprogestin [3H]RU38, 486 (RU486) and the progestin [3H]R5020 with the progesterone receptor (PR). In both MCF-7 and T47D human breast cancer cells, we have observed marked differences in the sedimentation properties of the PR on high salt sucrose gradients: while the R5020-receptor complexes sediment at approximately 4 S (4.4 +/- 0.1 S), the RU486-receptor sediments as a prominent 6 S species as well as a 4 S species. This binding is abolished by excess unlabelled R5020, RU486 or progesterone, but is unaffected by excess unlabelled hydrocortisone or dexamethasone, indicating that both the 4 S and 6 S species represent the PR and not glucocorticoid receptor. Although the relative distribution of 4 S and 6 S forms is not altered by treatment with DNAse or RNAse, exposure to 10 mM thioglycerol or to 3 M urea results in conversion of the 6 S to the 4 S form, suggesting that disulfide bonds and hydrophobic interactions are important in maintaining the integrity of the 6 S form. These findings suggest that the 6 S antiprogestin complex is formed as a result of the interaction of PR units with each other or with a different protein. This change in receptor association state may be an important aspect of the antiprogestin activity of RU486.
D001667:Binding, Competitive; D001943:Breast Neoplasms / Q000378:metabolism; D002460:Cell Line; D002499:Centrifugation, Density Gradient; D003851:Deoxyribonucleases / Q000378:metabolism; D004963:Estrenes / Q000378:metabolism*; D005260:Female; D006801:Humans; D015735:Mifepristone; D009649:Norpregnadienes / Q000378:metabolism*; D011397:Promegestone / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*; D012260:Ribonucleases / Q000378:metabolism; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D014508:Urea / Q000494:pharmacology
D004963:Estrenes; D009649:Norpregnadienes; D011980:Receptors, Progesterone; D013438:Sulfhydryl Compounds; D015735:Mifepristone; D014508:Urea; D011397:Promegestone; D003851:Deoxyribonucleases; D012260:Ribonucleases